-
BMS announces affordable drug price agreement with US government
09 Jan 2026 13:41 GMT
… free of charge to Medicaid. The company has also … tons of Eliquis active pharmaceutical ingredient (API) to … drug since it was first launched. It is an important treatment … Baraclude (entecavir) and Orencia SC (abatacept). This would make these medicines …
-
Effects of Non-Alcoholic Fatty Liver Disease on Baseline Histology and 96-Week Entecavir Response in Treatment-Naïve Chronic Hepatitis B
22 Dec 2025 18:48 GMT
… clinical data in the medical record. Diagnosis criteria of … (eg, weight loss, statins) alongside antiviral therapy to … and entecavir treatment failure in Chinese patients with chronic hepatitis B. … al. A randomized clinical trial of lipid metabolism modulation …
-
Nine Big Pharma to cut US drug prices in Most-favoured Nations deals
22 Dec 2025 08:26 GMT
… pharmaceutical ingredient to secure the supply chain. Other medicines … such as Reyataz, Sotyktu, Baraclude and Zeposia … will provide Epclusa for hepatitis C at around 90 … multiple sclerosis drug Mayzent and the cancer treatments Rydapt and …
-
Bristol Myers Squibb Announces Agreement with U.S. Government to Improve Affordability and Access to Critical Medicines for Americans
19 Dec 2025 23:19 GMT
… Baraclude® (entecavir), and Orencia®SC (abatacept), making these important medicines … nonsteroidal anti-inflammatory drugs (called NSAIDs), … not breastfeed during treatment with ELIQUIS. … REFORM HEALTH INSURANCE PHARMACEUTICAL BIOTECHNOLOGY
SOURCE: Bristol …
-
Is it safe to get vaccinated against hepatitis B?
16 Dec 2025 03:48 GMT
… .
Hepatitis B can be treated with antiviral medications such as tenofovir or entecavir … stay on treatment for life. Fortunately, a highly effective hepatitis B vaccine … if we start them on treatment and their viral loads become …
-
CDC Advisers Vote Against Hepatitis B Vaccine for All Newborns
06 Dec 2025 14:16 GMT
… are advised to consult their doctors and make an individual decision … with antiviral medications, such as tenofovir (Viread or Vemlidy) or entecavir (Baraclude), but … inject drugs, gay men, sex workers and immigrants for spreading hepatitis B …
-
Chronic hepatitis B therapeutics market to reach $3.2bn across 7MM in 2034
03 Dec 2025 02:08 GMT
… ’s report ‘Chronic Hepatitis B Therapeutics: Seven-Market Drug Forecast and Market … nucleos(t)ide analogues, specifically entecavir, Vemlidy (tenofovir alafenamide), and … analogues, demonstrating a shift among pharmaceutical companies to produce novel CHB …
-
Pegylated Interferon-α-Induced Functional Cure for Special Populations with Chronic Hepatitis B Virus Infection: Current Trends, Challenges and Prospection
22 Nov 2025 00:59 GMT
… up after discontinuation of medications in both CHB patients … of drug resistance to NAs.4 The ALLIANCE trial revealed … endpoints of clinical trials in chronic hepatitis B - … viraemia in chronic hepatitis B patients receiving entecavir treatment. Front Cell …
-
Impact of PC/BCP Mutations on Seroconversion and Relapse in HBeAg-Positive Chronic Hepatitis B Patients Treated with Nucleoside Analogues
13 Nov 2025 22:56 GMT
… may exhibit enhanced drug resistance, complicating treatment efforts.
To … ethical guidelines for medical research involving human subjects … tenofovir and entecavir in treatment of chronic hepatitis B and … : a randomized-controlled trial. J Hepatol. 2025 …
-
Bispecific T-Cell Engager Shows Promise for Hepatitis B
11 Nov 2025 08:46 GMT
… infected with hepatitis B virus (HBV), reduced hepatitis B … Viread or Vemlidy) or entecavir (Baraclude) can keep HBV replication … , the Food and Drug Administration approved the company … trial, in which 16 men with viral suppression on antiretroviral treatment …